Could the next anti-cancer drug be made from seafood?

September 17, 2018, University of Salford
Credit: CC0 Public Domain

Biomedical scientists at the University of Salford found that sugars from the common cockle (Cerastoderma edule) were approximately as effective as some standard chemotherapy drugs at relative lower dosage.

And they say 'cockle-chemo' could be particularly suitable for children as it is potentially less toxic and less likely to cause unhealthy side-effects.

Publishing in the journal Marine Drugs, the Salford team have tested the mollusc-derived sugars with positive results against leukaemia, breast, lung and and tumours.

Lead researcher Dr. David Pye, Director of Child Cancer Research Charity Kidscan at the University of Salford, said: "Polysaccharides (sugars) derived from mammals have long been a source of experimentation by cancer scientists but to date with inconclusive results. Certain applications have actually helped the cancer to grow.

"We opted to look at shellfish instead, not least because they are much cheaper and easier to source and well as being rich in sugars.

"They have a different structure from which we are starting to derive a number of potential drugs which with further refinement have the potential to work alongside more traditional treatments."

He said extracting a mix of polysaccharides from cockles was a simple procedure and that the impact on tumours was encouraging.

Between 2-3 out of every 10 children in Britain with cancer diagnoses will not survive to adulthood, a fact which drives research at the Kidscan labs in Salford.

"What is really significant about this is not so much the seafood source but that fact that sugars of this chemical structure work effectively at tolerable levels for children.

"A lot of children's are watered down versions of adult ones, and they target and stop . Clearly, as cell division is a central process of growth and development they hit children's health disproportionately.

"The 'Holy Grail' of children's is to maximise the destruction of the whilst minimising damage to normal cells and tissues. Sugars as therapeutic treatments should help to minimise harmful side-effects."

Explore further: Matcha green tea kills cancer stem cells in tests

More information: undefined undefined et al. Antiproliferative Activity of Glycosaminoglycan-Like Polysaccharides Derived from Marine Molluscs, Marine Drugs (2018). DOI: 10.3390/md16020063

Related Stories

Matcha green tea kills cancer stem cells in tests

August 31, 2018
Matcha, the green tea packed with antioxidants, is often hailed as containing properties which prevent disease. Scientists in Salford, UK have shed a ray of light on the claim by testing it on cancer stem cells – with surprising ...

Vitamin B2 deficiency puts cancer cells into hibernation

January 30, 2018
Cancer stem cells can be put into "hibernation" by a little-known drug called diphenyleneiodonium (DPI) according to researchers from the University of Salford, UK. DPI effectively switches off the cancer stem cells, preventing ...

Novel drug cocktails strengthen targeted cancer therapies while lessening side effects

August 1, 2018
Mount Sinai researchers have discovered that certain drug cocktails help targeted therapies attack cancer more efficiently while lessening common side effects, according to a study published today in Cancer Research.

Vitamin C and antibiotics—a new one-two punch for knocking-out cancer stem cells.

June 12, 2017
Cancer stem cells, which fuel the growth of fatal tumours, can be knocked out by a one-two combination of antibiotics and Vitamin C in a new experimental strategy, published by researchers at the University of Salford, UK.

Stem cell 'marking' study offers alterative hypothesis of cancer metastasis

January 18, 2017
Stem cells are among the most energetically activated, migratory and proliferative sub-populations of tumour cells, according to observations by scholars at the Biomedical Research Centre at the University of Salford.

New drug technology may improve treatment options for aggressive types of breast cancer

June 20, 2018
Purdue University researchers have developed a new technology that may change how one of the most aggressive types of breast cancer is treated.

Recommended for you

Week 34 of pregnancy reduces breast cancer risk: study

October 23, 2018
Women's bodies undergo a "striking" change during a specific week of pregnancy that can significantly reduce their risk of developing breast cancer later in life, scientists said Tuesday.

New kind of compound shows early promise against prostate cancer

October 23, 2018
A new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer, a new study finds.

New combination treatment flips the switch on melanoma cells

October 23, 2018
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that most cancer cells have found ways to remove this "finger—commonly, by breaking the action of a gene called p53 that ...

Desperate & duped? GoFundMe means big bucks for dubious care

October 23, 2018
People seeking dubious, potentially harmful treatment for cancer and other ailments raised nearly $7 million over two years from crowdfunding sites, a study found.

Marker found for condition that causes numerous tumors

October 23, 2018
UT Southwestern researchers have made a major advance in uncovering the biology of how thousands of disfiguring skin tumors occur in patients troubled by a genetic disorder called neurofibromatosis type 1 (NF1). This scientific ...

Urban and rural rates of childhood cancer survival the same, study finds

October 23, 2018
Childhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new study from the Brown School at Washington University in St. Louis.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.